Skip to NavigationSkip to content

News

0
astrazeneca image
British firm partners with Celgene, Innate and Juno following Q1 revenue hike
0
Chief executive Peter George image
British firm snaps up Surrey company that has unlicensed drugs in oncology and haematology
0
Novartis image
LCZ696 granted a Promising Innovative Medicine designation following good results
0
Novartis image
Companies rack up single and double digit year-on-year growth

Features

EU image

The ABPI’s Dr Virginia Acha answers your questions about how companies can prepare for new legislation on conducting multi-state clinical trials...